ArticleBrain, behavior, & immunity - health2025
Comparison of cerebrospinal fluid biomarkers in patients with severe COVID-19 neurological outcomes and Alzheimer's disease.
Fernanda G Q Barros-Aragão et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
2025
this papercites it